Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury mechanical versus embolic focal ischemia in spontaneously hypertensive rats

Stroke

Volumn 33, Issue 11, 2002, Pages 2711-2717

  Aoki, Toshiaki ^a   Sumii, Toshihisa ^a   Mori, Tatsuro ^a   Wang, Xiaoying ^a   Lo, Eng H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Brain edema; Metalloproteinases; Neuroprotection; Stroke; Tissue plasminogen activator

Indexed keywords

GELATINASE B; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN EMBOLISM; BRAIN ISCHEMIA; BRAIN PROTECTION; IMMUNOHISTOCHEMISTRY; LASER DOPPLER FLOWMETRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; ZYMOGRAPHY;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; EVANS BLUE; FIBRINOLYTIC AGENTS; IMMUNOHISTOCHEMISTRY; INTRACRANIAL EMBOLISM; MALE; MATRIX METALLOPROTEINASE 9; RATS; RATS, INBRED SHR; REPERFUSION INJURY; TISSUE PLASMINOGEN ACTIVATOR; UP-REGULATION;

EID: 0036843258     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000033932.34467.97     Document Type: Article

References (35)

1. ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator in acute hemispheric stroke. JAMA. 1995;274: 1017-1025.
2. Hacke W, Brott T, Caplan L, Meier D, Fieschi C, von Kummer R, Donnan G, Heiss WD, Wahlgren NG, Spranger M, Boysen G, Marler JR. Thrombolysis in acute ischemic stroke: Controlled trials and clinical experience. Neurology. 1999;53(suppl 4):s3-s15.
3. NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
4. Chopp M, Zhang RL, Zhang ZG, Jiang Q. The clot thickens: Thrombolysis and combination therapies. Acta Neurochir Suppl. 1999;73:67-71.
5. Larrue V, von Kummer R, del Zoppo G, Bluhmki E. Hemorrhagic transformation in acute ischemic stroke: Potential contributing factors in the ECASS study. Stroke. 1999;28:957-960.
6. NINDS rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous TPA therapy for ischemic stroke. Stroke. 1997;28:2109-2118.
7. McAuley MA. Rodent models of focal ischemia. Cerebrovasc Brain Metab Rev. 1995;7:153-181.
8. Hara T, Mies G, Hossmann KA. Effect of thrombolysis on the dynamics of infarct evolution after clot embolism of middle cerebral artery in mice. J Cereb Blood Flow Metab. 2000;20:1483-1491.
9. Hata R, Maeda K, Hermann D, Mies G, Hossmann KA. Dynamics of regional brain metabolism and gene expression after middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab. 2000;20:306-315.
10. Hata R, Maeda K, Hermann D, Mies G, Hossmann KA. Evolution of brain infarction after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab. 2000;20:937-946.
11. Jiang Q, Zhang ZG, Chopp M, Helpern JA, Ordidge RJ, Garcia JH, Marchese BA, Qing ZX, Knight RA. Temporal evolution and spatial distribution of the diffusion constant of water in rat brain after transient middle cerebral artery occlusion. J Neurol Sci. 1993;120:123-130.
12. Jiang Q, Zhang RL, Zhang ZG, Ewing JR, Divine GW, Chopp M. Diffusion, T2, and perfusion weighted MRI of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat. J Cereb Blood Flow Metab. 1998;18:758-767.
13. Rosenberg GA. Ischemic brain edema. Prog Cardiovasc Dis. 1999;42: 209-216.
14. Asahi M, Asahi K, Wang X, Lo EH. Reduction of tissue plasminogen activator induced hemorrhage and brain injury by free radical spin trapping after focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 2000;20:452-457.
15. Sumii T, Singhal AB, Asahi M, Shimizu-Sasamata M, Suzuki M, Miyata K, Lo EH. Protective effect of pamiteplase, a modified tPA, in a rat model of embolic stroke. Neuroreport. 2001;12:615-618.
16. Sumii T, Lo EH. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke. 2002;33:831-836.
17. Zhang ZG, Zhang RL, Jiang Q, Raman SB, Cantwell L, Chopp M. A new rat model of thrombotic focal cerebral ischemia. J Cereb Blood Flow Metab. 1997;17:123-135.
18. Meng W, Wang X, Asahi M, Kano T, Asahi K, Ackerman RH, Lo EH. Effects of tissue type plasminogen activator in embolic versus mechanical models of focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1999;19:1316-1322.
19. Zea Longa E, Weinstein PR, Carlson S, Cummins R. Reversible middle artery occlusion without craniectomy. Stroke. 1989;20:84-91.
20. Asahi M, Wang X, Mori T, Sumii T, Jung J, Moskowitz MA, Fini ME, Lo EH. Effects of matrix metalloproteinase 9 gene knockout on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci. 2001;21:7724-7732.
21. Asahi M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, Lo EH. Role of matrix metalloproteinase 9 in focal cerebral ischemia: Effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab. 2000;20:1681-1690.
22. Asahi M, Sumii T, Fini ME, Itohara S, Lo EH. Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia. Neuroreport. 2001;12:3003-3007.
23. Wang X, Jung J, Asahi M, Chwang W, Russo L, Moskowitz MA, Dixon CE, Fini ME, Lo EH. Effects of matrix metalloproteinase 9 gene knockout on morphological and motor outcomes after traumatic brain injury. J Neurosci. 2000;20:7037-7043.
24. Wang X, Mori T, Jung J, Fini ME, Lo EH. Secretion of matrix metalloproteinase-2 and -9 following traumatic injury in rat cortical cultures and involvement of MAP kinase. J Neurotrauma. 2002;19: 615-625.
25. del Zoppo GJ. Microvascular changes during cerebral ischemia and reperfusion. Cerebrovasc Brain Metab Rev. 1994;6:47-96.
26. Hallenback JM, Dutka AJ. Current concepts of reperfusion injury. Arch Neurol. 1990;47:1245-1254.
27. Siesjo BK. Free radicals and brain damage. Cerebrovasc Brain Metab Rev. 1989;1:165-211.
28. Jacewicz M, Tanabe J, Pulsinelli WA. The CBF threshold and dynamics for focal cerebral infarction in spontaneously hypertensive rats. J Cereb Blood Flow Metab. 1992;12:359-370.
29. Mun-Bryce S, Rosenberg GA. Matrix metalloproteinases in cerebrovascular disease. J Cereb Blood Flow Metab. 1998;18:1163-1172.
30. Gasche Y, Copin JC, Sugawara T, Fujimura M, Chan PH. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab. 2001;21:1393-1400.
31. Liu WH, Chen XM, Fu B. Thrombin stimulates MMP-9 mRNA expression through AP-1 pathway in human mesangial cells. Acta Pharmacol Sin. 2000;21:641-645.
32. Kuroiwa T, Shibutani M, Okeda R. Blood-brain barrier disruption and exacerbation of ischemia brain edema after restoration of flow in experimental focal cerebral ischemia. Acta Neuropathol (Berl). 1988;76: 62-68.
33. Kuroiwa T, Ting P, Martinez H, Klatzo I. The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion. Acta Neuropathol (Berl). 1985;68:122-129.
34. Heo JH, Lucero J, Abumiya T, Koizol JA, Copeland BR, del Zoppo GJ. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab. 1999;19:624-633.
35. Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke. 1998;29:2189-2195.